Analyst Research Report Snapshot

Title:

Cipla Limited

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

08 Apr 2014

Pages:

38

Type:

AcrobatPDF

Companies referenced:

CIPL.NS

Available for Immediate Download
Summary:

Cipla Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Cipla Limited required for business and competitor intelligence needs - A study of the major internal and external factors affecting Cipla Limited in the form of a SWOT analysis - An in-depth view of the business model of Cipla Limited including a breakdown and examination of key business segments - Intelligence on Cipla Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Cipla Limited, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Cipla (or 'the company') is an India-based manufacturer of prescription drugs, animal products, OTC (over-the-counter) products, bulk drugs, flavors and fragrances, and agrochemicals. It is headquartered in Mumbai, India, and employed 27,562 people as of March 31, 2013. The company recorded net revenues of INR82,793.3 million (approximately $1,515.1 million) during the financial year ended March 2013 (FY2013), an increase of 17.9% over FY2012. The operating profit* of the company was INR20,886.5 million (approximately $382.2 million) during FY2013, an increase of 40.5% over FY2012. The net profit was INR15,448.5 million (approximately $282.7 million) in FY2013, an increase of 35% over FY2012. *Earnings before interest and taxes. Reasons to Purchase: - Gain understanding of Cipla Limited and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Cipla Limited as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Cipla Limited’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.